| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 700087 | Bisoxireno[1,10a:3,4]phenanthro[3,2-b]furan-9(7aH)-one, 1,2, 3,4,4a,5,6,11a,11b,11c-decahydro-4,4,8,11c-tetramethyl-, [4aR-(4a.alpha.,6aS*,7a.beta.,10aR*,11a.beta.,11b.alpha.,11c.beta,)]- (9CI) | 0.00216534295403403 | 0.13109811 |
| NSC 363787 | Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- | 0.00216534295403404 | 0.41909763 |
| NSC 636476 | cis-Difluorobis[1-(phenyl-2,4,6-trimethyl)butane-1,3- dionato]titanium(IV) | 0.00228818143845077 | 0.6754702 |
| NSC 677617 | Furan-2,3-dione, tetrahydro-4-acetoxy- 4-(1-phenyl-2-propen-1-yl)-5-(2,2-dimethyl-1,3-dioxolan-4-yl)- | 0.00228818143845077 | 0.30738586 |
| NSC 742295 | (11aS)-8-(5-[4-(1,3-benzothiazol-2-yl)phenoxy]pentyloxy)-7-methoxy-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one | 0.00228818143845077 | 0.28055575 |
| NSC 699382 | Null | 0.00270237426478987 | 0.15929565 |
| NSC 672120 | Oxireno[9,10]cyclodeca[1,2-b]furan-6,9(7H,10aH)-dione, 1a,2,3,7a,8,10b-hexahydro-1a,5-dimethyl-8-methylene-, stereoisomer | 0.00289834947687854 | 0.17997046 |
| NSC 38643 | Lenamycin | 0.00313644776247638 | 0.32765865 |
| NSC 626539 | Null | 0.00313644776247638 | 0.45566644 |
| NSC 656203 | Discorhabdin B | 0.00313644776247638 | 0.28115224 |